amg and folks
IMHO 3m and the whole patch thing will lead to nothing, just as i said it would in early April. IMHO 3m are only looking at supplying the hardware for this proposed patch
quote form the ann in April
"allows OBJ to offer a full range of development and production programs to partner projects supported by 3M Drug Delivery Systems technology and production expertise"
end quote
It is, and was then still only "in Vitro" work which means they are yet to get it out of a test tube, which means the patch is still pre clinical and a decade away from being on the market at best, and thats even it it works at all, which imho it does not
to support this, If it did, 3m and Obj would move heaven and earth to accelerate out of in vitro tests, IMHO the whole thing is a ruse in saying 3 m are busy, if something has legs it gets funded out of in vitro to begin with and immediatley
Its when you hit the Human trials the $$$ costs come in.
So imho i would not expect any good news come October
The FMCG/FIM thing may have legs, but the $$$$$ involved in it will be tiny compared to a Pharma application
And with a billion shares on offer, i wouldnt expect much out of it
Again all IMHO and DYOR
- Forums
- ASX - By Stock
- WFL
- in 2 months time
in 2 months time, page-5
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online